AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD)
SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzhei
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session
GainersWorksport (NASDAQ:WKSP) shares increased by 5.0% to $0.52 during Friday's after-market session. The company's market cap stands at $12.4 million. Jeffs Brands (NASDAQ:JFBR) shares rose 4.98% to
Harley-Davidson Price Target Cut to $45.00/Share From $50.00 by BMO Capital
Harley-Davidson Price Target Cut to $45.00/Share From $50.00 by BMO Capital
Harley-Davidson Is Maintained at Overweight by Morgan Stanley
Harley-Davidson Is Maintained at Overweight by Morgan Stanley
Damo: Maintaining the Harley-Davidson (HOG.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $50.00 to $51.00.
Damo: Maintaining the Harley-Davidson (HOG.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $50.00 to $51.00.
Morgan Stanley Maintains Overweight on Harley-Davidson, Raises Price Target to $51
Morgan Stanley analyst Adam Jonas maintains Harley-Davidson with a Overweight and raises the price target from $50 to $51.